CN Patent
CN102482219A — 吡喃酮和吡啶酮衍生物的制备方法
Assigned to Shionogi and Co Ltd · Expires 2012-05-30 · 14y expired
What this patent protects
本发明提供新型的抗流感药物的合成中间体即吡喃酮衍生物和吡啶酮衍生物、它们的制备方法、以及它们的使用方法。
USPTO Abstract
本发明提供新型的抗流感药物的合成中间体即吡喃酮衍生物和吡啶酮衍生物、它们的制备方法、以及它们的使用方法。
Drugs covered by this patent
- Xofluza (BALOXAVIR MARBOXIL) · Roche
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.